Literature DB >> 2666417

Proteoglycan biosynthesis in murine monocytic leukemic (M1) cells before and after differentiation.

D J McQuillan1, M Yanagishita, V C Hascall, M Bickel.   

Abstract

Murine monocytic leukemic (M1) cells were cultured in the presence of [3H]glucosamine and [35S]sulfate. Labeled proteoglycans were purified by anion exchange chromatography and characterized by gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis in combination with chemical and enzymatic degradation. M1 cells synthesize a single predominant species of proteoglycan which distributes almost equally between the cell and medium after 17 h labeling. The cell-associated proteoglycan has an overall size of about 135 kDa and contains three to five chondroitin sulfate chains (28-31 kDa each) attached to a chondroitinase-generated core protein of 28 kDa. The synthesis and subsequent secretion of this proteoglycan was enhanced 4-5-fold in cells induced to differentiate into macrophages. This was not a phenomenon of arrest in the G0/G1 stage of the cell cycle, since density inhibited undifferentiated cells arrested at this stage did not increase proteoglycan synthesis. The chondroitin sulfate chains contained exclusively chondroitin 4- and 6-sulfate; however, the ratio of these two disaccharides differed between the medium- and cell-associated proteoglycans, and changed during progression of the cells into a fully differentiated phenotype. Pulse-chase kinetics indicate the presence of two distinct pools of proteoglycan; one that is secreted very rapidly from the cell after a approximately 1-h lag, and a second pool that is turned over in the cell with a half-time of approximately 3.5 h. Subtle differences in the glycosylation patterns of the medium- and cell-associated species are consistent with synthesis of two pools. Papain digestion suggests that the chondroitin sulfate chains are clustered on a small protease resistant peptide. The data suggest that this proteoglycan is similar to the serglycin proteoglycan family.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Isolation and purification of proteoglycans.

Authors:  N S Fedarko
Journal:  Experientia       Date:  1993-05-15

Review 2.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

3.  Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts.

Authors:  L Kopper; A Bankfalvi; R Mihalik; T T Glant; J Timar
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Proteoglycan synthesis in human erythroleukaemia (HEL) cells.

Authors:  B P Schick; S Senkowski-Richardson
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.